4//SEC Filing
Feider Stephen 4
Accession 0001415889-25-023023
CIK 0001674632other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 4:29 PM ET
Size
8.9 KB
Accession
0001415889-25-023023
Insider Transaction Report
Form 4
Feider Stephen
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-08-22$5.10/sh+4,413$22,506→ 49,916 total - Sale
Common Stock
2025-08-22$17.01/sh−4,413$75,083→ 45,503 total - Exercise/Conversion
Employee Stock Option (right to buy)
2025-08-22−4,413→ 99,695 totalExercise: $5.10Exp: 2033-09-13→ Common Stock (4,413 underlying)
Footnotes (3)
- [F1]Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025.
- [F2]The weighted average sale price for the transaction reported was $17.0140 and the range of prices were between $17.00 and $17.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
Documents
Issuer
Beta Bionics, Inc.
CIK 0001674632
Entity typeother
Related Parties
1- filerCIK 0002048588
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 4:29 PM ET
- Size
- 8.9 KB